November 7, 2016 / 2:18 PM / 9 months ago

BRIEF-Cocrystal gives interim data from early-stage study for Hepatitis C treatment

Nov 7 (Reuters) - Cocrystal Pharma Inc

* Press release - Cocrystal announces positive interim data from an ongoing phase 1 study with cc-31244 for the treatment of chronic hepatitis c infection Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below